Verdiva Bio
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
London, UKverdivabio.com ↗
Total raised
€399M
€399,019,441
Funding rounds
1
Investors
7
distinct backers
Active since
2025-01
latest 2025-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-01-10 | Series A | €399M | Forbion,General Atlantic,Lilly Asia Ventures,Logos Capital,LYFE Capital,OrbiMed+1 more | View deal → |